Myriad Genetics and SOPHiA Genetics team up on prostate cancer test
Go back to Myriad Genetics and SOPHiA Genetics team up on prostate cancer test| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,691,379 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.82 +0.06 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.76 | 52 Week High | $45.34 | |||
| Open | $5.72 | 52 Week Low | $15.92 | |||
| Day High | $5.86 | P/E | 2.50 | |||
| Day Low | $5.60 | EPS | $2.33 | |||
| Volume | 2,099,658 | |||||
| (NASDAQ: SOPH) | Delayed: 7.35 +0.30 (4.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.05 | 52 Week High | $ | |||
| Open | $6.99 | 52 Week Low | $ | |||
| Day High | $7.41 | P/E | N/A | |||
| Day Low | $6.90 | EPS | $ | |||
| Volume | 455,640 | |||||



